Natixis Exelixis, Inc. Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Exelixis, Inc. stock. As of the latest transaction made, Natixis holds 38,068 shares of EXEL stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

38,068

Previous 1 3806700.0%

Holding current value

$1.33 Million

Previous $0 Infinity%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.96 - $27.6 $835,951 - $1.05 Million	38,067 Added 3806700.0%	38,068 $987,000
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $9,984 - $11,845	-495 Reduced 99.8%	1 $0
Q4 2023 Feb 13, 2024	BUY	$19.25 - $24.13 $9,548 - $11,968	496 New	496 $11,000
Q4 2022 Feb 24, 2023	BUY	$14.96 - $17.39 $55,426 - $64,429	3,705 New	3,705 $59,000
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $578,650 - $750,470	-35,500 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.95 - $25.56 $637,225 - $907,380	35,500 New	35,500 $647,000
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $293,579 - $360,646	-14,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $262,977 - $354,640	14,300 New	14,300 $287,000
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $824,464 - $1.07 Million	-39,887 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $656,540 - $1.09 Million	39,887 New	39,887 $947,000
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $2.83 Million - $3.53 Million	-187,058 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$17.68 - $22.65 $2.54 Million - $3.26 Million	143,816 Added 332.58%	187,058 $3.31 Million
Q2 2019 Aug 13, 2019	BUY	$18.93 - $24.75 $818,571 - $1.07 Million	43,242 New	43,242 $924,000
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $4.87 Million - $6.15 Million	-248,338 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $3.18 Million - $5.08 Million	233,091 Added 1528.77%	248,338 $4.89 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $6.39 Million - $9.02 Million	-402,807 Reduced 96.35%	15,247 $270,000
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $7.31 Million - $8.85 Million	394,017 Added 1639.21%	418,054 $9 Million
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $12.2 Million - $17.5 Million	-549,128 Reduced 95.81%	24,037 $532,000
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $12.9 Million - $16.4 Million	531,559 Added 1277.6%	573,165 $17.4 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $971,500 - $1.22 Million	41,606	41,606 $1.01 Million

Others Institutions Holding EXEL

# of Institutions

495

Shares Held

244M

Call Options Held

2.4M

Put Options Held

2.21M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account